{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:11:54Z","timestamp":1788786714150,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2007,7,24]]},"DOI":"10.1007\/s10096-007-0340-2","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T09:11:18Z","timestamp":1182417078000},"page":"571-581","source":"Crossref","is-referenced-by-count":109,"title":["Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study"],"prefix":"10.1007","volume":"26","author":[{"given":"J.","family":"Oksi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nikoskelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hiekkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lauhio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Peltomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pitk\u00e4ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Granlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-A.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Valtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Viljanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,22]]},"reference":[{"key":"340_CR1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED et al (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089\u20131134","journal-title":"Clin Infect Dis"},{"key":"340_CR2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","volume":"107","author":"AC Steere","year":"1987","unstructured":"Steere AC, Schoen RT, Taylor E (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107:725\u2013731","journal-title":"Ann Intern Med"},{"key":"340_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2004.027367","volume":"64","author":"R Dinser","year":"2005","unstructured":"Dinser R, Jendro MC, Schnar S, Zedler H (2005) Antibiotic treatment of Lyme borreliosis: what is the evidence? Ann Rheum Dis 64:519\u2013523","journal-title":"Ann Rheum Dis"},{"key":"340_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere AC (2001) Lyme disease. N Engl J Med 345:115\u2013125","journal-title":"N Engl J Med"},{"key":"340_CR5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","volume":"323","author":"EL Logigian","year":"1990","unstructured":"Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323:1438\u20131444","journal-title":"N Engl J Med"},{"key":"340_CR6","first-page":"357","volume":"263","author":"W Kristoferitsch","year":"1987","unstructured":"Kristoferitsch W, Baumhackl U, Sluga E, Stanek G, Zeiler K (1987) High-dose penicillin therapy in meningopolyneuritis Garin\u2013Bujadoux\u2013Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg [A] 263:357\u2013364","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"key":"340_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF01713336","volume":"24","author":"MH Ziska","year":"1996","unstructured":"Ziska MH, Donta ST, Demarest FC (1996) Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 24:182\u2013186","journal-title":"Infection"},{"key":"340_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0163-4453(94)91105-3","volume":"29","author":"P Wahlberg","year":"1994","unstructured":"Wahlberg P, Granlund H, Nyman D, Panelius J, Sepp\u00e4l\u00e4 I (1994) Treatment of late Lyme borreliosis. J Infect 29:255\u2013261","journal-title":"J Infect"},{"issue":"Suppl 1","key":"340_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/516171","volume":"25","author":"ST Donta","year":"1997","unstructured":"Donta ST (1997) Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 25(Suppl 1):52\u201356","journal-title":"Clin Infect Dis"},{"key":"340_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms, and a history of Lyme disease. N Engl J Med 345:85\u201392","journal-title":"N Engl J Med"},{"key":"340_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-136-5-200203050-00024","volume":"136","author":"LH Sigal","year":"2002","unstructured":"Sigal LH (2002) Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology. Ann Intern Med 136:413\u2013419","journal-title":"Ann Intern Med"},{"key":"340_CR12","first-page":"741","volume":"108","author":"G Stanek","year":"1996","unstructured":"Stanek G, O\u2019Connell S, Cimmino M et al (1996) European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108:741\u2013747","journal-title":"Wien Klin Wochenschr"},{"key":"340_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(89)90195-6","volume":"124","author":"MK Viljanen","year":"1989","unstructured":"Viljanen MK, Punnonen J (1989) The effect of storage of antigen-coated polystyrene microwells on the detection of antibodies against Borrelia burgdorferi by enzyme immunoassay (EIA). J Immunol Methods 124:137\u2013141","journal-title":"J Immunol Methods"},{"key":"340_CR14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/JCM.33.9.2260-2264.1995","volume":"33","author":"J Oksi","year":"1995","unstructured":"Oksi J, Uksila J, Marjam\u00e4ki M, Nikoskelainen J, Viljanen MK (1995) Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41 kilodalton flagellin and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis. J Clin Microbiol 33:2260\u20132264","journal-title":"J Clin Microbiol"},{"key":"340_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1034\/j.1600-0463.2001.d01-178.x","volume":"109","author":"J Oksi","year":"2001","unstructured":"Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK (2001) Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 109:581\u2013588","journal-title":"APMIS"},{"key":"340_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.39.6.753","volume":"39","author":"JJ Halperin","year":"1989","unstructured":"Halperin JJ, Luft BJ, Anand AK, Rogue CT, Alvarez O, Volkman DJ, Dattwyler RJ (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753\u2013759","journal-title":"Neurology"},{"key":"340_CR17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","volume":"117","author":"RJ Dattwyler","year":"2005","unstructured":"Dattwyler RJ, Wormser GP, Rush TJ et al (2005) A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr 117:393\u2013397","journal-title":"Wien Klin Wochenschr"},{"key":"340_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1099\/00207713-42-3-378","volume":"42","author":"G Baranton","year":"1992","unstructured":"Baranton G, Postic D, Saint-Girons I et al (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS 461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378\u2013383","journal-title":"Int J Syst Bacteriol"},{"key":"340_CR19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/clinids\/17.4.708","volume":"17","author":"AP Dam van","year":"1993","unstructured":"van Dam AP, Kuiper H, Vos K et al (1993) Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17:708\u2013717","journal-title":"Clin Infect Dis"},{"key":"340_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/506936","volume":"43","author":"F Strle","year":"2006","unstructured":"Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V (2006) Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 43:704\u2013710","journal-title":"Clin Infect Dis"},{"key":"340_CR21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD). A randomised double masked clinical trial. Neurology 60:1923\u20131930","journal-title":"Neurology"},{"key":"340_CR22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","volume":"60","author":"RF Kaplan","year":"2003","unstructured":"Kaplan RF, Trevino RP, Johnson GM et al (2003) Cognitive function in post-treatment Lyme disease. Do additional antibiotics help? Neurology 60:1916\u20131922","journal-title":"Neurology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0340-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0340-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T06:17:30Z","timestamp":1587622650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0340-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,22]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,7,24]]}},"alternative-id":["340"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0340-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,22]]}}}